This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Geneuro Sa. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Francois Curtin
Introduction
Francois Curtin is a notable inventor based in Chambesy, Switzerland. He has made significant contributions to the field of medicine, particularly in the development of antiretroviral drugs. His work focuses on targeting human endogenous retroviruses, which are crucial in the fight against viral infections.
Latest Patents
Francois Curtin holds a patent for an antiretroviral drug that specifically targets the human endogenous retrovirus type W (HERV-W). The invention involves an antibody, a fragment, or a derivative thereof, directed against the HERV-W Envelope protein (HERV-W Env). This innovative approach also includes a composition that combines the antibody with a retroviral reverse-transcriptase inhibitory drug, enhancing its effectiveness as an antiretroviral treatment.
Career Highlights
Throughout his career, Curtin has worked with various companies, including Geneuro SA and Scalabrino, Giuseppe. His experience in these organizations has contributed to his expertise in developing groundbreaking medical solutions.
Collaborations
Francois Curtin has collaborated with notable professionals in his field, including Herve Perron and Alois Bernhardt Lang. These partnerships have further enriched his research and development efforts.
Conclusion
Francois Curtin's innovative work in the field of antiretroviral drugs showcases his commitment to advancing medical science. His patent targeting HERV-W represents a significant step forward in the treatment of viral infections.